Combined tocainide and quinidine therapy for patients with coronary artery disease

S. G. Kim, A. D. Mercando, J. D. Fisher

Research output: Contribution to journalArticlepeer-review

Abstract

Twenty patients who had coronary artery disease with frequent ventricular premature complexes were given tocainide and quinidine alone and in combination to evaluate the effectiveness of these three treatment modes in reducing ventricular premature complexes. The two drugs, when combined in less than maximal, well-tolerated doses, did not cause dose-related side effects and were more effective than maximal doses of either drug used alone.

Original languageEnglish (US)
Pages (from-to)39-44
Number of pages6
JournalCardiology Board Review
Volume5
Issue number2
StatePublished - Jan 1 1988

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Combined tocainide and quinidine therapy for patients with coronary artery disease'. Together they form a unique fingerprint.

Cite this